Sorrento Therapeutics Announces the Formation of Sorrento Therapeutics Mexico for Commercialization of COVI-STIX and Development of Sorrento’s Portfolio of COVID-19 Products in Mexico and Parts of Latin America Sorrento Therapeutics has established a Subsidiary Company in Mexico - Sorrento Therapeutics Mexico.Sorrento’s Mexican importer of record has received an initial importation permit from Mexico...

Sorrento Receives EUA Approval and Import License From Mexico Authority COFEPRIS For COVI-STIX™ (COVID-19 Virus Rapid Antigen Detection Test) and Plans Product Launch With Initial Shipments in July Sorrento received official EUA registration and product import license: COFEPRIS EUA registration number “OFICIO: CAS/10720/2021”.Sorrento is establishing its “Sorrento Mexico Ltd” subsidiary to...

Sorrento Announces Addition of COVI-STIX™ (Covid-19 Virus Rapid Antigen Detection Test) to the Official Mexican Government List of Emergency Use Approved Point of Care Rapid Antigen Tests COVI-STIX has been added to the official government list of point of care rapid antigen tests useful for the detection of SARS-CoV-2 in Mexico...

Medical Marijuana, Inc.'s HempMeds® México Ships RSHO-X, First-Ever Federally Approved Cannabidiol (CBD) Product February 8 SAN DIEGO, Feb. 05, 2016 (GLOBE NEWSWIRE) -- HempMeds® Mexico is the sales, marketing and distribution company for the first cannabidiol (CBD) hemp oil product granted special permission by the...

Medical Marijuana, Inc. Celebrates Mexico’s Access to RSHO-X Cannabidiol (CBD) Hemp Oil; Historic Occasion Results in Global News Coverage SAN DIEGO, Feb. 03, 2016 (GLOBE NEWSWIRE) -- It took him more than eight hours travel by bus to get to Mexico City.  Around mid-day, Abelardo Maldonado Constantino emerged from the COFEPRIS...